Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
Patent Number: 5582823
Date of First Priority Issue: Friday August 23rd, 1985
Date Issued: Tuesday December 10th, 1996
Assignee: Amgen Inc. (Thousand Oaks, CA)
Inventor: Souza, Lawrence M. (Thousand Oaks, CA)
From Class: Use
Comments: No comments
This patent covers the use of human pluripotent granulocyte colony stimulating factor for induction of granulocyte production, as well as for reducing bacterially mediated inflammation.
The use of growth factors such as the one described has expanded in recent years to other types of stem cells besides hematopoietic stem cells. It will be interesting to see first what the new name for the pluripotent granulocyte-CSF is, as well as to see if it has activity on other types of stem cells.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.